# Trip.com Group Ltd: financial statements, quarterly

TCOM · Nasdaq · CIK 1269238 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tcom.md) · [Financials](/companies/tcom/financials.md) · [Filings](/companies/tcom/filings.md) · [Insiders](/companies/tcom/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tcom/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2014 (2014-12-31) | FY2015 (2015-12-31) | FY2016 (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.8](/filings/0001104659-16-113453.md) | [2.8](/filings/0001104659-17-023278.md) | [2.8](/filings/0001104659-18-025739.md) | [2.8](/filings/0001104659-18-025739.md) | [3.1](/filings/0001104659-19-015257.md) | [2.9](/filings/0001193125-20-102627.md) | [2.8](/filings/0001193125-21-081372.md) | [3.1](/filings/0001193125-22-123585.md) | [2.5](/filings/0001193125-23-080422.md) | [5.9](/filings/0001193125-24-122196.md) | [6.6](/filings/0001193125-25-078429.md) | [5.7](/filings/0001193125-26-183379.md) |
| Current assets | $bn | [2.8](/filings/0001104659-15-030417.md) | [6.3](/filings/0001104659-16-113453.md) | [6.6](/filings/0001104659-17-023278.md) | [9.1](/filings/0001104659-18-025739.md) | [11.5](/filings/0001104659-19-015257.md) | [9.8](/filings/0001193125-20-102627.md) | [8.9](/filings/0001193125-21-081372.md) | [10.4](/filings/0001193125-22-123585.md) | [8.9](/filings/0001193125-23-080422.md) | [12.5](/filings/0001193125-24-122196.md) | [15.4](/filings/0001193125-25-078429.md) | [17.3](/filings/0001193125-26-183379.md) |
| Total assets | $bn | [5.0](/filings/0001104659-15-030417.md) | [18.3](/filings/0001104659-16-113453.md) | [20.8](/filings/0001104659-17-023278.md) | [24.9](/filings/0001104659-18-025739.md) | [27.0](/filings/0001104659-19-015257.md) | [28.8](/filings/0001193125-20-102627.md) | [28.7](/filings/0001193125-21-081372.md) | [30.1](/filings/0001193125-22-123585.md) | [27.8](/filings/0001193125-23-080422.md) | [30.9](/filings/0001193125-24-122196.md) | [33.2](/filings/0001193125-25-078429.md) | [38.2](/filings/0001193125-26-183379.md) |
| Current liabilities | $bn | [2.0](/filings/0001104659-15-030417.md) | [5.2](/filings/0001104659-16-113453.md) | [4.4](/filings/0001104659-17-023278.md) | [6.5](/filings/0001104659-18-025739.md) | [10.0](/filings/0001104659-19-015257.md) | [9.9](/filings/0001193125-20-102627.md) | [8.9](/filings/0001193125-21-081372.md) | [10.4](/filings/0001193125-22-123585.md) | [8.9](/filings/0001193125-23-080422.md) | [10.2](/filings/0001193125-24-122196.md) | [10.1](/filings/0001193125-25-078429.md) | [11.2](/filings/0001193125-26-183379.md) |
| Total liabilities | $bn | [3.4](/filings/0001104659-15-030417.md) | [8.5](/filings/0001104659-16-113453.md) | [9.9](/filings/0001104659-17-023278.md) | [11.6](/filings/0001104659-18-025739.md) | [14.1](/filings/0001104659-19-015257.md) | [13.4](/filings/0001193125-20-102627.md) | [13.1](/filings/0001193125-21-081372.md) | [12.8](/filings/0001193125-22-123585.md) | [11.4](/filings/0001193125-23-080422.md) | [13.5](/filings/0001193125-24-122196.md) | [13.6](/filings/0001193125-25-078429.md) | [13.6](/filings/0001193125-26-183379.md) |
| Long-term debt | $bn | [1.3](/filings/0001104659-15-030417.md) | [2.8](/filings/0001104659-16-113453.md) | [5.0](/filings/0001104659-17-023278.md) | [4.5](/filings/0001104659-18-025739.md) | [3.5](/filings/0001104659-19-015257.md) | [2.8](/filings/0001193125-20-102627.md) | [3.5](/filings/0001193125-21-081372.md) | [1.7](/filings/0001193125-22-123585.md) | [1.9](/filings/0001193125-23-080422.md) | [2.7](/filings/0001193125-24-122196.md) | [2.8](/filings/0001193125-25-078429.md) | [1.6](/filings/0001193125-26-183379.md) |
| Current portion of debt | $bn | not reported | [2.0](/filings/0001104659-16-113453.md) | [1.0](/filings/0001104659-17-023278.md) | [2.5](/filings/0001104659-18-025739.md) | [5.2](/filings/0001104659-19-015257.md) | [4.4](/filings/0001193125-20-102627.md) | [5.2](/filings/0001193125-21-081372.md) | [6.3](/filings/0001193125-22-123585.md) | [4.7](/filings/0001193125-23-080422.md) | [3.6](/filings/0001193125-24-122196.md) | [2.7](/filings/0001193125-25-078429.md) | [2.8](/filings/0001193125-26-183379.md) |
| Short-term borrowings | $bn | [0.6](/filings/0001104659-15-030417.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.5](/filings/0001104659-15-030417.md) | [6.9](/filings/0001104659-16-113453.md) | [10.3](/filings/0001104659-17-023278.md) | [13.0](/filings/0001104659-18-025739.md) | [12.6](/filings/0001104659-19-015257.md) | [14.9](/filings/0001193125-20-102627.md) | [15.4](/filings/0001193125-21-081372.md) | [17.2](/filings/0001193125-22-123585.md) | [16.3](/filings/0001193125-23-080422.md) | [17.2](/filings/0001193125-24-122196.md) | [19.4](/filings/0001193125-25-078429.md) | [24.4](/filings/0001193125-26-183379.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 649,583,574 at 2025-12-31, from the cover of the [20-F filed 2026-04-28](/filings/0001193125-26-183379.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.